VIENNA — Ixekizumab (Taltz), an interleukin-17A inhibitor that’s already approved for the treatment of psoriatic arthritis and axial spondyloarthritis in adults appears likely to be granted […]

VIENNA — To maintain gout in remission, nurses in a rheumatology service do better than doctors in implementing a straightforward treat-to-target (T2T) strategy, according to a […]

George Bakris, MD, an internationally recognized expert in hypertension and diabetic kidney disease, has died at the age of 72 years. At the time of his […]

A position statement released by the American Headache Society (AHS) earlier this year recommended adding calcitonin gene-related peptide (CGRP)–targeting medications to the list of first-line therapies […]

In a survey of adults with moderate to severe AD participating in a patient support program for upadacitinib in the United States, 86.8% reported that their […]

With avian influenza spreading quickly around the globe, the virus has more opportunities to mutate and cause problems for people. By some calculations, H5N1 bird flu […]

The U.S. Preventive Services Task Force (USPSTF) is recommending that clinicians provide comprehensive, intensive behavioral interventions for children 6 years and older who have a high […]

The American Diabetes Association (ADA) 84th Scientific Sessions, taking place June 21-24, 2024, will showcase new endpoints for currently available diabetes management tools and highlight best […]

A single course of treatment with emotional awareness and expression therapy (EAET) was associated with a significantly greater reduction in chronic pain severity than cognitive-behavioral therapy […]